# BioSolvix

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/biosolvix

- Industry: Biotechnology
- Headquarters: Yangsan, South Korea
- Website: www.biosolvix.com/
- Latest round: Seed (Oct 1, 2023)
- Investors on record: 2

## About

Founded in 2023 and based in Seoul, South Korea, BioSolvix operates as a biotechnology company that develops technology used for alternative animal testing to cure cancer and other diseases. In April 2024, the firm raised an amount of venture funding from investor DT&CRO Co., Ltd. As of 2024, the company is headed by its CEO Suyoung Choi.

The company offers organoid research services that facilitate alternative animal testing appropriate for humans and patients. The firm service range includes IPS and organoid banking, cancer organoid, drug screening, and toxicity study. Additionally, its service scope also includes organs on a chip and possessed technology.

## Funding rounds

- Seed, Oct 1, 2023 — Korea Tech Incubator for Startup, Scale Up Partners

## Investors

- Korea Tech Incubator for Startup — Seed
- Scale Up Partners (https://capitalatlas.ai/funds/scale-up-partners) — Seed